Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
calcium lysinate
- Development stage
- Unknown
- Lead developer
- Puneet Laboratories
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Calcium lysinate is a chemical compound consisting of calcium bound to the amino acid L-lysine. It is utilized as a source of calcium and lysine in dietary supplements and pharmaceutical formulations. Calcium is vital for bone health, muscle contraction, and nerve signaling, while L-lysine is an essential amino acid that plays a role in protein synthesis and may enhance the intestinal absorption of calcium while reducing its renal excretion. It is manufactured as an active pharmaceutical ingredient (API) by companies such as Niksan Pharmaceutical for use in products addressing calcium deficiency and osteoporosis.
- Other names
- calcium L-lysinateL-lysine calcium salt
Beyond the preview
Go deeper on calcium lysinate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on calcium lysinate.